US health regulator has closed out the warning letter, which was issued to a unit of Divis Laboratories in Visakhapatnam, following evaluation of corrective actions...
A warning letter has been issued by the US health regulator to Mylan for violations of good manufacturing norms, including data integrity lapses and failure...
The US health regulator has issued an import alert on Divis Laboratories Visakhapatnam unit-II. Divis Laboratories has said in a statement that “The United States...
IRDAI has issued guidelines for the acquisition of shares in listed insurance companies under that the acquirer will be required to adhere to the fit...